| Year |
Citation |
Score |
| 2003 |
Walker-Daniels J, Hess AR, Hendrix MJ, Kinch MS. Differential regulation of EphA2 in normal and malignant cells. The American Journal of Pathology. 162: 1037-42. PMID 12651595 DOI: 10.1016/S0002-9440(10)63899-0 |
0.594 |
|
| 2002 |
Walker-Daniels J, Riese DJ, Kinch MS. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Molecular Cancer Research : McR. 1: 79-87. PMID 12496371 |
0.628 |
|
| 2002 |
Zelinski DP, Zantek ND, Walker-Daniels J, Peters MA, Taparowsky EJ, Kinch MS. Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase. Journal of Cellular Biochemistry. 85: 714-20. PMID 11968011 DOI: 10.1002/Jcb.10186 |
0.379 |
|
| 2001 |
Dodge Zantek N, Walker-Daniels J, Stewart J, Hansen RK, Robinson D, Miao H, Wang B, Kung HJ, Bissell MJ, Kinch MS. MCF-10A-NeoST: A new cell system for studying cell-ECM and cell-cell interactions in breast cancer Clinical Cancer Research. 7: 3640-3648. PMID 11705887 |
0.691 |
|
| 2000 |
Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Molecular and Cellular Biology. 20: 5828-39. PMID 10913166 DOI: 10.1128/Mcb.20.16.5828-5839.2000 |
0.548 |
|
| 1999 |
Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS. Overexpression of the EphA2 tyrosine kinase in prostate cancer. The Prostate. 41: 275-80. PMID 10544301 DOI: 10.1002/(Sici)1097-0045(19991201)41:4<275::Aid-Pros8>3.0.Co;2-T |
0.634 |
|
| Show low-probability matches. |